Please login to the form below

Not currently logged in
Email:
Password:

dimethyl fumarate

This page shows the latest dimethyl fumarate news and features for those working in and with pharma, biotech and healthcare.

Biogen files Tecfidera follow-up in the US

Biogen files Tecfidera follow-up in the US

The new drug – diroximel fumarate (BIIB098) – is partnered with Alkermes and has been developed to improve the safety profile of Tecfidera (dimethyl fumarate), particularly with regard to its gastrointestinal tolerability. ... Earlier this month

Latest news

More from news
Approximately 11 fully matching, plus 42 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2017 Deal Watch January 2017

    Biogen. Patent settlement. Tecfidera (dimethyl fumarate). 1, 250. Merrimack Pharamceuti-cals. Ipsen.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Executive vice president of Biogen leaves Executive vice president of Biogen leaves

    Kingsley joined Biogen in 2010 as senior VP and during his tenure Biogen introduced five new therapies including successfully launching Tecfidera (dimethyl fumarate) – the most prescribed oral treatment for multiple sclerosis.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics